Picard Medical, INC. 8-K Filing

Ticker: PMI · Form: 8-K · Filed: Dec 4, 2025 · CIK: 2030617

Sentiment: neutral

Filing Stats: 554 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2025-12-04 08:00:58

Key Financial Figures

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On December 4, 2025, Duffy Elmer, Engineering Project Manager of Picard Medical, Inc. (the "Company") presented in vitro data on the Emperor Total Artificial Heart at the 31 st Annual Meeting of the International Society for Mechanical Circulatory Support in Vienna, Austria. A copy of the abstract that Mr. Elmer presented on is furnished as Exhibit 99.1 and the slide deck utilized during his presentation is furnished as Exhibit 99.2, each of which is incorporated by reference herein. The information in this report and the exhibits attached hereto shall not be deemed to be "filed" for purposes of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

01

Item 9.01. Financial (d) Exhibits The following exhibits are being filed herewith: Exhibit No. Description 99.1 Abstract of The Emperor Total Artificial Heart, dated December 4, 2025. 99.2 Presentation Slide Deck, dated December 4, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Picard Medical, Inc. By: /s/ Patrick NJ Schnegelsberg Name: Patrick NJ Schnegelsberg Title: Chief Executive Officer Dated: December 4, 2025 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing